Cognitive status and use of analgesics and anxiolytics in residents of nursing homes in the Czech Republic
Language English Country New Zealand Media electronic-ecollection
Document type Journal Article
PubMed
30587943
PubMed Central
PMC6294074
DOI
10.2147/cia.s188601
PII: cia-13-2511
Knihovny.cz E-resources
- Keywords
- analgesics, anxiety, anxiolytics, dementia, pain,
- MeSH
- Analgesics therapeutic use MeSH
- Anti-Anxiety Agents therapeutic use MeSH
- Pain complications drug therapy MeSH
- Dementia complications MeSH
- Homes for the Aged standards MeSH
- Cognitive Dysfunction complications MeSH
- Quality of Health Care * MeSH
- Humans MeSH
- Pain Measurement MeSH
- Nursing Homes standards MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Anxiety complications drug therapy MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- Analgesics MeSH
- Anti-Anxiety Agents MeSH
BACKGROUND: The treatment of pain and treatment of anxiety are two of the most complex issues in nursing homes worldwide, mainly because of the large numbers of people with cognitive impairment who reside in this environment. AIM: The aim of this study was to investigate the administration of analgesics and anxiolytics to people living in nursing homes, taking into account cognitive status. METHODS: For this cross-sectional study, we used data from 404 residents who lived in nine randomly selected nursing homes in the Czech Republic and participated in the Czech-Austrian Long-Term Care Research Project called DEMDATA. Information about medication administration was obtained from medical records. Cognitive impairment was evaluated by the Mini-Mental State Examination, and pain was measured by the Pain Assessment in Advanced Dementia. To measure anxiety, we used the Behavioral Pathology in Alzheimer's Disease Rating Scale in residents with severe-to-moderate dementia and also the standardized questionnaire EuroQol in other residents. RESULTS: In all, 68% (95% CI 62-74) of residents with pain did not receive any analgesic medication and 31% (95% CI 25-38) of residents were administered some analgesics and continued to report pain. The lowest reported occurrence of pain, as well as the lowest prevalence of analgesic administration, was in residents with moderate-to-severe dementia. We found that an alarming percentage of residents in the nursing homes were not treated sufficiently. CONCLUSION: This study indicates that treatment effects should be better monitored.
Danube University Krems 3500 Krems Austria
Faculty of Physical Education and Sport Charles University Prague Czech Republic
See more in PubMed
Seitz D, Purandare N, Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr. 2010;22(7):1025–1039. PubMed
Toot S, Swinson T, Devine M, Challis D, Orrell M. Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis. Int Psychogeriatr. 2017;29(2):195–208. PubMed
Creighton AS, Davison TE, Kissane DW. The prevalence, reporting, and treatment of anxiety among older adults in nursing homes and other residential aged care facilities. J Affect Disord. 2018;227:416–423. PubMed
Takai Y, Yamamoto-Mitani N, Okamoto Y, Koyama K, Honda A. Literature review of pain prevalence among older residents of nursing homes. Pain Manag Nurs. 2010;11(4):209–223. PubMed
Horgas AL, Tsai PF. Analgesic drug prescription and use in cognitively impaired nursing home residents. Nurs Res. 1998;47(4):235–242. PubMed
Closs SJ, Barr B, Briggs M. Cognitive status and analgesic provision in nursing home residents. Br J Gen Pract. 2004;54(509):919–921. PubMed PMC
Corbett A, Husebo B, Malcangio M, et al. Assessment and treatment of pain in people with dementia. Nat Rev Neurol. 2012;8(5):264–274. PubMed
Guthrie B, Clark SA, Mccowan C. The burden of psychotropic drug prescribing in people with dementia: a population database study. Age Ageing. 2010;39(5):637–642. PubMed
Saarelainen L, Tolppanen A-M, Koponen M, et al. Risk of hip fracture in benzodiazepine users with and without Alzheimer disease. J Am Med Dir Assoc. 2017;18(1):87.e15–87.e87. PubMed
Saarelainen L, Tolppanen AM, Koponen M, et al. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study. Int J Geriatr Psychiatry. 2018;33(4):583–590. PubMed
Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0174730. PubMed PMC
Auer S, Linsmayer E, Beránková A, et al. DEMDATA: the Austrian-Czech institutional long term care project – design and protocol of a two-centre cross sectional study. BMC Health Serv Res. 2017;17(1):296. PubMed PMC
Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch Gen Psychiatry. 1983;40(7):812. PubMed
Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003;4(1):9–15. PubMed
Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry. 1987;48(Suppl):9–15. PubMed
EuroQol Group EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. PubMed
Binnekade TT, Scherder EJA, Maier AB, et al. Pain in patients with different dementia subtypes, mild cognitive impairment, and subjective cognitive impairment. Pain Med. 2018;19(5):920–927. PubMed
Hunnicutt JN, Ulbricht CM, Tjia J, Lapane KL. Pain and pharmacologic pain management in long-stay nursing home residents. Pain. 2017;158(6):1091–1099. PubMed PMC
Fain KM, Alexander GC, Dore DD, Segal JB, Zullo AR, Castillo-Salgado C. Frequency and predictors of analgesic prescribing in U.S. nursing home residents with persistent pain. J Am Geriatr Soc. 2017;65(2):286–293. PubMed PMC
Flo E, Husebø B. Treating pain in dementia – are we good enough? J Pain Palliat Care Pharmacother. 2015;29(3):303–304. PubMed
Achterberg W, Lautenbacher S. Editorial: pain in dementia: a distressing combination of several factors. Curr Alzheimer Res. 2017;14(5):468–470. PubMed
Lukas A, Mayer B, Fialová D, et al. Treatment of pain in European nursing homes: results from the Services and Health for Elderly in Long TERm Care (SHELTER) study. J Am Med Dir Assoc. 2013;14(11):821–831. PubMed
Tan EC, Jokanovic N, Koponen MP, Thomas D, Hilmer SN, Bell JS. Prevalence of analgesic use and pain in people with and without dementia or cognitive impairment in aged care facilities: a systematic review and meta-analysis. Curr Clin Pharmacol. 2015;10(3):194–203. PubMed
Goyal AR, Bergh S, Engedal K, Kirkevold M, Kirkevold Ø. Anxiety, anxiety symptoms, and their correlates in persons with dementia in Norwegian nursing homes: a cause for concern. Dement Geriatr Cogn Disord. 2017;43(5–6):294–305. PubMed
Neville C, Teri L. Anxiety, anxiety symptoms, and associations among older people with dementia in assisted-living facilities. Int J Ment Health Nurs. 2011;20(3):195–201. PubMed
Seignourel PJ, Kunik ME, Snow L, Wilson N, Stanley M. Anxiety in dementia: a critical review. Clin Psychol Rev. 2008;28(7):1071–1082. PubMed PMC
